OKYO Pharma Results Presentation Deck
June 2023, 25 slides
  1. OKYO Pharma
  2. Related Decks
  3. Results Presentation Decks
targeting dry overcoming limitations of eye disease with current dry eye therapies | OKYO Pharma
disclaimer | OKYO Pharma
| OKYO Pharma
pipeline focus to treat dry eye disease | OKYO Pharma
phase trial start in patients announced on may | OKYO Pharma
dry eye disease overview ocular surface damage inflammation pain key symptoms of dry eye risk growth factors | OKYO Pharma
limits of current standard of care | OKYO Pharma
global market expected to reach billion by | OKYO Pharma
a conjugated peptide | OKYO Pharma
derived peptide a potential regulator of inflammation pain | OKYO Pharma
targeting receptor | OKYO Pharma
membrane anchoring improves potency durability as | OKYO Pharma
validation efficacy in dry eye mouse model | OKYO Pharma
normalized goblet cells reduced inflammatory cells a a | OKYO Pharma
corneal neuropathic pain in dry eye disease | OKYO Pharma
reduced corneal neuropathic pain in mouse model | OKYO Pharma
addresses inflammation and pain components of dry eye | OKYO Pharma
overcoming limitations of current dry eye therapies clinical development | OKYO Pharma
development a | OKYO Pharma
phase trial design rota | OKYO Pharma
patent protection up to | OKYO Pharma
comparable companies sig | OKYO Pharma
experienced team with considerable drug development synergy | OKYO Pharma
investment highlights | OKYO Pharma
dry eye disease and ocular pain | OKYO Pharma
See More
OKYO Pharma
Results Presentation Decks
Biotechnology Decks
Healthcare Decks
Explore Topics
Inflammation
Pharma
Recent decks by OKYO Pharma
Shareholder Engagement
March 2020
See all presentations by OKYO Pharma (2 decks)
Related decks
BenevolentAI
Investor Presentation
September 2024
Nuvectis Pharma
Investor Presentation
July 2023
NeuroBo Pharmaceuticals
Investor Presentation
January 2024
NeuroBo Pharmaceuticals
Securities Offering
October 2022
Bausch Health Companies
Results
May 2021
Bausch Health Companies
Results
November 2021
NeuroBo Pharmaceuticals
Investor Presentation
December 2023
BioNTech
Results
May 2020
Recent decks by OKYO Pharma
See all presentations (2 decks)
Shareholder Engagement
March 2020
BenevolentAI
Investor Presentation
September 2024
Nuvectis Pharma
Investor Presentation
July 2023
NeuroBo Pharmaceuticals
Investor Presentation
January 2024
NeuroBo Pharmaceuticals
Securities Offering
October 2022
Bausch Health Companies
Results
May 2021
Bausch Health Companies
Results
November 2021
NeuroBo Pharmaceuticals
Investor Presentation
December 2023
BioNTech
Results
May 2020
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights